MichaelBrouseFallonMDFACP, FAASLD, AGAF
Gastroenterology • Phoenix, AZHepatology & Liver Transplantation
Chair, Department of Medicine University of Arizona College of Medicine Phoenix
Dr. Fallon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 N. 12th street
Office 1082
Phoenix, AZ 85006Phone+1 602-839-5916
Education & Training
Yale-New Haven Medical CenterFellowship, Transplant Hepatology, 1989 - 1990- Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987
University of Virginia School of MedicineClass of 1984
Certifications & Licensure
AZ State Medical License 2016 - 2026
AL State Medical License 1994 - 2025
TX State Medical License 2008 - 2024
CT State Medical License 1986 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Start of enrollment: 2006 May 01
- Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome Start of enrollment: 2004 Jun 01
- The Effect of Sorafenib on Portal Pressure Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Predictors of long-term clinical outcomes after TIPS: An ALTA group study.Yael R Nobel, Justin R Boike, Nikhilesh R Mazumder, Bartley Thornburg, Rachel Hoffman
Hepatology. 2025-04-01 - 4 citationsAlcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cance...Pojsakorn Danpanichkul, Kwanjit Duangsonk, Markos Kalligeros, Michael B Fallon, Chawinthorn Vuthithammee
Alimentary Pharmacology & Therapeutics. 2025-03-01 - Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.Pojsakorn Danpanichkul, Kwanjit Duangsonk, Vincent L Chen, Preenapun Saokhieo, Disatorn Dejvajara
Hepatology. 2025-02-11
Press Mentions
Buffmire Lecture Sheds Light on Intimate Partner ViolenceOctober 17th, 2024- ABRC Grant to Support Research of Lung Disease Linked to SmokingMarch 29th, 2023
- Joyce Lee-Iannotti, MD, Named Arizona Researcher of the Year by the American College of PhysiciansJanuary 25th, 2023
- Join now to see all
Grant Support
- Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndromeUNIVERSITY OF ARIZONA2023–2027
- Novel Paxillin-FAK Inhibitors for the Treatment of Liver FibrosisFAKNOSTICS, LLC2024–2025
- Mediators Of Pulmonary Vasodilatation In Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Mediators Of Pulmonary Vasodilatation In Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2008
- Pentoxifylline For Cirrhotic Patients With Hepatopulmonary SyndromeNational Center For Research Resources2005–2007
- Hepatopulmonary Investigative GroupNational Center For Research Resources2005–2007
- Hepatopulmonary Syndrome Investigative GroupNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Tight Junction In Cholestasis--A Molecular ApproachNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1995
- Tight Junction In Cholestasis--A Molecular ApproachNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
